Eli Lilly to acquire Bothell biotech company for $1.5 billion - The Seattle Times
Eli Lilly is acquiring three vaccine/infectious-disease biotechs in a ~$20B buying spree, including a Bothell company for $1.5B, pivoting toward a new infectious disease portfolio. The multi-deal announcement signals Lilly is deploying GLP-1 cash flows into pipeline diversification, but raises capital-allocation risk for a stock already priced for perfection near $1,085.
What happened
Eli Lilly is acquiring three vaccine/infectious-disease biotechs in a ~$20B buying spree, including a Bothell company for $1.5B, pivoting toward a new infectious disease portfolio.
The read · May 27
Fade the LLY pop short-term — three simultaneous acquisitions totaling ~$20B signal management urgency, and with insiders selling and the stock up 1.9% on the day, the risk/reward favors a tactical short into the Goldman conference.
Wrong if
LLY re-rates higher if management frames the acquisitions as an accretive vaccine platform story with near-term revenue visibility; any positive GLP-1 data released concurrently would also squeeze shorts hard.
CoverageSource: Google News · Published here WED, MAY 27 · 9:00 AM ET · the only report in this recordHow this is decided →
The chart · LLYTradingView · third-party feed, not the Wire’s licensed closes
🔒 Click to interact · scroll moves the page
The story1 min read
The read, in fullWhy it matters
Lilly is simultaneously closing three infectious-disease acquisitions totaling ~$20B — a level of deal activity that historically flags management anxiety about the core GLP-1 pipeline's durability. Insider activity shows 0 buys vs. 2 sells in the last 30 days, and the stock is already rich at $1,085 with a consensus skew of 19 Buys vs. only 1 Sell (limited upside re-rating room). The Goldman Global Healthcare Conference is a near-term event where any skeptical analyst Q&A on capital deployment could pressure the name.
The arc● Open · no developments yet
· Published
The read above, as written. kept as written
Next · what would move this
A dated catalyst on JUN 11 · 1-2 weeks. Follow to be told when one lands.
Receipts
Google News — the original9:00 AM
Research, not advice.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →